SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Spekulatius who wrote (69588)1/23/2022 1:30:41 AM
From: bruwin1 Recommendation

Recommended By
petal

  Read Replies (1) | Respond to of 78462
 
What no one wants to face up to and admit, especially those "medical experts" who advise those in government, is the fact that ALL Respiratory Viruses MUTATE, and as they do so they become more TRANSMISSIBLE but Less VIRULENT ...... This is EXACTLY what is now being seen with the 4th Variant, OMICRON.

A Respiratory Virus can ONLY survive IN, and be transmitted FROM, a Human Host. Therefore to become more VIRULENT will just expedite its own demise.
The Spanish Flu killed MILLIONS after the 1st world war, today it's a Non-Entity.



To: Spekulatius who wrote (69588)1/23/2022 1:10:02 PM
From: Paul Senior1 Recommendation

Recommended By
petal

  Read Replies (1) | Respond to of 78462
 
AMZN. And EKS, fwiw, Amazon which Spekulatius is buying, was also favorably mentioned by one of the panelists.

As for my last pick, there is no easier way to make money in the market than to buy a great company under pressure due to short-term concerns.There are plenty these days.
Amazon.com has dramatically lagged other big tech stocks and the market in the past year. Its core retail business is facing difficult comparisons postpandemic. First-quarter revenue and profit expectations may be too high, and comps won’t get easier until the third quarter. Also, retail margins have disappointed. Amazon’s retail business is trading in line with Walmart [WMT] on an enterprise value to sales basis, based on 2023 numbers. If you were to separate out the high-multiple and high-growth advertising business, you could argue that you were paying negative value for the retail segment. The margin disappointment relates to the magnitude of square-footage additions in the past two years. When expansion slows, margins will expand again.
The market is so fixated on retail that it has missed the value of Amazon Web Services, or AWS, which is conservatively worth 12 times sales, or $1.15 trillion, based on 2023 estimates. We expect this business to grow revenue by $14 billion to $15 billion in 2021, a 30% increase. Given 10% to 15% of TAM [total addressable market] penetration by AWS and cloud-computing companies, there is a long runway for growth. We think Amazon’s stock could double in four years, assuming a multiple of 10 times sales for AWS and 35 times normalized earnings for the retail and advertising business, based on 2027 estimates.
The reason I'm reluctant to add is that I can't use any of my metrics to come up with a value estimate for AMZN. I've no idea how to value AWS or estimate its growth. I can see AMZN retail services every day, and we are AMZN Prime. But I'm blind to the other aspects of AMZN.